13379-86-7 Usage
Explanation
Different sources of media describe the Explanation of 13379-86-7 differently. You can refer to the following data:
1. The compound's full name, which describes its structure and components.
2. The molecular formula representing the compound's constituent elements and their quantities.
3. The core structure of the compound, consisting of a three-carbon chain with a hydroxyl group attached to the second carbon.
4. An amine group attached to the central propan-2-ol group through a propan-2-yl chain, indicating potential biological activity.
5. A phenoxy group with a methylsulfanyl substituent at the 2nd position, contributing to the compound's sulfur-containing nature.
6. The presence of a sulfur atom in the form of a methylsulfanyl group, which may influence the compound's properties and reactivity.
7. The compound's potential use in the development of drugs or medications, though further research and testing are required.
8. The propan-2-ylamino group suggests that the compound may have basic amine properties, which could be relevant to its potential pharmaceutical applications.
9. The compound's specific properties, potential functions, and safety would need to be investigated through laboratory experiments and analyses.
Central Group
Propan-2-ol
Side Group 1
Propan-2-ylamino
Side Group 2
2-(methylsulfanyl)phenoxy
Sulfur Content
Methylsulfanyl group
Potential Applications
Pharmaceutical
Biological Activity
Basic amine
Further Study
Laboratory testing
Check Digit Verification of cas no
The CAS Registry Mumber 13379-86-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,7 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13379-86:
(7*1)+(6*3)+(5*3)+(4*7)+(3*9)+(2*8)+(1*6)=117
117 % 10 = 7
So 13379-86-7 is a valid CAS Registry Number.
13379-86-7Relevant articles and documents
Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
-
, (2008/06/13)
The present invention provides a pharmaceutical composition for controlled release of 4-(2-hydroxy-3-isopropylamino-propoxy) indole in the intestinal tract, admixed with sodium lauryl sulphate, and enteric coated.
